Literature DB >> 8968744

Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation.

R J Scott1, N J Froggatt, R C Trembath, D G Evans, S V Hodgson, E R Maher.   

Abstract

Desmoid tumours are generally very rare but occur about 100 times more frequently in the colorectal cancer predisposition syndrome familial adenomatous polyposis (MIM 175100), being represented in about 10% of patients. In addition to desmoid disease occurring in familial adenomatous polyposis (FAP) there exist familial infiltrative fibromatosis (MIM 135290) kindreds where there is no evidence of FAP. Previously we have described a kindred with familial infiltrative fibromatosis (FIF) in which desmoid tumours were associated with nonpolyposis colorectal cancer. FAP is caused by mutations in the APC gene and various genotype-phenotype relationships have been defined including reports that colorectal polyposis is less severe with mutations 5' to codon 157 and that the risk of desmoid tumours is high in FAP patients with APC gene mutations between codons 1444 and 1598. There is relatively little information on the phenotype of APC gene mutations 3' to codon 1598; however, one large family has been reported with a mutation at codon 1987 which presents with a highly variable phenotype which includes desmoid disease. We screened our original FIF kindred and three further families with a similar phenotype for mutations in the APC gene. A 4 bp frameshift deletion in codon 1962 was identified in the original FIF kindred and two further apparently unrelated families. Haplotype analysis suggests a common origin for the APC mutation in all three families. Affected individuals had no evidence of congenital hypertrophy of the retinal pigment epithelium. Colorectal polyposis was variable, and most affected patients had either none or a few late onset polyps. These findings demonstrate (i) that FAP and FIF are allelic, and (ii) that APC gene mutations which truncate the APC protein distal to the beta-catenin binding domain are associated with desmoid tumours, absent CHRPE and variable but attenuated polyposis expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968744     DOI: 10.1093/hmg/5.12.1921

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  27 in total

Review 1.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

2.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli.

Authors:  C Soravia; T Berk; L Madlensky; A Mitri; H Cheng; S Gallinger; Z Cohen; B Bapat
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

3.  Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families.

Authors:  W Friedl; R Caspari; M Sengteller; S Uhlhaas; C Lamberti; M Jungck; M Kadmon; M Wolf; J Fahnenstich; J Gebert; G Möslein; E Mangold; P Propping
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity.

Authors:  R J Scott; C Meldrum; R Crooks; A D Spigelman; J Kirk; K Tucker; D Koorey
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  Inherited colorectal cancer syndromes.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-08

6.  Colonic adenomatous polyposis syndromes: clinical management.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2008-11

7.  Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status.

Authors:  K Heinimann; B Müllhaupt; W Weber; M Attenhofer; R J Scott; M Fried; S Martinoli; H Müller; Z Dobbie
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

8.  Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene.

Authors:  J D Brensinger; S J Laken; M C Luce; S M Powell; G H Vance; D J Ahnen; G M Petersen; S R Hamilton; F M Giardiello
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

9.  Familial adenomatous polyposis: experience from a study of 1164 unrelated german polyposis patients.

Authors:  Waltraut Friedl; Stefan Aretz
Journal:  Hered Cancer Clin Pract       Date:  2005-09-15       Impact factor: 2.857

10.  Profuse familial adenomatous polyposis with an adenomatous polyposis coli exon 3 mutation.

Authors:  S Nasioulas; I T Jones; D J St John; R J Scott; S M Forrest; R J McKinlay Gardner
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.